National Bank of Canada’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-782,701
| Closed | -$17.1M | – | 2617 |
|
|
2025
Q1 | $17.1M | Sell |
782,701
-602,899
| -44% | -$13.2M | 0.02% | 474 |
|
|
2024
Q4 | $44.2M | Buy |
1,385,600
+1,385,080
| +266,362% | +$44.2M | 0.05% | 273 |
|
|
2024
Q3 | $15K | Sell |
520
-80
| -13% | -$2.31K | ﹤0.01% | 1812 |
|
|
2024
Q2 | $21.8K | Hold |
600
| – | – | ﹤0.01% | 1797 |
|
|
2024
Q1 | $25.2K | Buy |
+600
| New | +$25.2K | ﹤0.01% | 1769 |
|
|
2023
Q4 | – | Sell |
-393
| Closed | -$14.6K | – | 2528 |
|
|
2023
Q3 | $14.6K | Buy |
393
+36
| +10% | +$1.34K | ﹤0.01% | 1890 |
|
|
2023
Q2 | $32.5K | Buy |
+357
| New | +$32.5K | ﹤0.01% | 1734 |
|